scispace - formally typeset
H

Hiroshi Maeda

Researcher at Kumamoto University

Publications -  915
Citations -  67944

Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.

Papers
More filters
Journal ArticleDOI

Chemotherapy for bladder cancer with neocarzinostatin: Evaluation of systemic administration☆

Sadaaki Sakamoto, +3 more
- 01 Jan 1980 - 
TL;DR: The results suggest that neocarzinostatin may be of value in treatment of bladder cancer, and side effects were reversible and disappeared with the interruption of chemotherapy.
Journal ArticleDOI

Effect of Magnetic Field and High Pressure on the Superconductivity of the New High- T c Oxide Bi–Sr–Ca–Cu–O

Takehiko Matsumoto, +7 more
- 20 Apr 1988 - 
TL;DR: In this paper, the electrical resistances of the multiphase new high-Tc superconducting oxides Bi-Sr-Ca-Cu-O have been measured in the magnetic field and under hydrostatic pressure.
Journal ArticleDOI

Use of corfolsin dalopate following cardiac surgery in a neonate.

Hiroshi Iranami, +5 more
- 01 Aug 2002 - 
TL;DR: A FEMALE neonate, weighing 2,690 g, developed severe cyanosis immediately after birth, and was diagnosed as having complex heart anomaly, total correction surgery was scheduled to take place on the patient's twenty-first day of life.
Journal ArticleDOI

Therapeutic intervention with chicken egg white ovomacroglobulin and a new quinolone on experimental Pseudomonas keratitis.

Shinichi Miyagawa, +4 more
- 01 Aug 1994 - 
TL;DR: In vitro inhibitory effects of proteolytic activity with ovoM is useful in preventing stromal degradation in P. aeruginosa keratitis, and the combined effects of OvoM and the new quinolone, ofloxacin (OFLX) on experimental Pseudomonas aerug initis were investigated.
Journal ArticleDOI

Isolation and characterization of monoclonal antibodies specific for chondroitin sulfate E

Ippei Watanabe, +10 more
- 01 Sep 2015 - 
TL;DR: New monoclonal antibodies are established, termed E-12C and E-18H, by using CSE that contained more than 70% of E-units as an immunogen and specifically recognize the E-unit of CSE.